Announce Date | 05/20/2025 |
EPS Normalized Actual | $0.8 (Beat by $0.028) |
EPS GAAP Actual | $0.8 (Beat by $0.028) |
Revenue Actual | $2.289B |
Revenue Surprise | Beat by $2289M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2029 | 0 | INF | 0 | 0 | 4 |
Jul 2028 | 8.44 | 23.34 | 8.24763 | 8.84402 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.39 | 0.39 | 2.289B | 13.29% | 2289M |
FQ1 2025 (Jan 2025) | 0.41 | 0.41 | 2.2574B | 12.51% | 2257.4M |
FQ4 2024 (Oct 2024) | 1.07 | 1.07 | 2.1388B | 12.19% | 2138.8M |
FQ3 2024 (Jul 2024) | 1.1 | 1.1 | 2.1895B | 10.79% | 2189.5M |
FQ2 2024 (Apr 2024) | 0.86 | 0.86 | 1.9848B | 100% | 1984.8M |
FQ1 2024 (Jan 2024) | 5.47 | 5.47 | 1.9751B | 16.2% | 1975.1M |
FQ4 2023 (Oct 2023) | 0.63 | 0.63 | 1.8781B | 16.76% | 1878.1M |
FQ3 2023 (Jul 2023) | 0.74 | 0.74 | 1.9533B | 20.62% | 1953.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Jul 2028) | 1.54 | -- | 1.51945 | 1.57949 | 12 |
FQ2 2028 (Apr 2028) | 1.44 | -- | 1.42078 | 1.47692 | 12 |
FQ1 2028 (Jan 2028) | 1.54 | -- | 1.5168 | 1.58322 | 12 |
FQ4 2027 (Oct 2027) | 1.19 | -- | 1.17412 | 1.22051 | 11 |
FQ3 2027 (Jul 2027) | 1.4 | -- | 1.38132 | 1.4359 | 11 |
FQ2 2027 (Apr 2027) | 1.25 | -- | 1.23332 | 1.28205 | 11 |
FQ1 2027 (Jan 2027) | 1.47 | -- | 1.44785 | 1.51125 | 11 |
FQ4 2026 (Oct 2026) | 1.38 | -- | 1.36158 | 1.41538 | 11 |
FQ3 2026 (Jul 2026) | 2.03813 | -- | 2.01093 | 2.09039 | 11 |
FQ2 2026 (Apr 2026) | 1.72518 | 77.39 | 1.70216 | 1.76941 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Jul 2028) | 10.86B | -- | 10.75B | 11.08B | 12 |
FQ2 2028 (Apr 2028) | 10.37B | -- | 10.26B | 10.57B | 13 |
FQ1 2028 (Jan 2028) | 0B | -- | 0B | 0B | 24 |
FQ4 2027 (Oct 2027) | 9.38B | -- | 9.29B | 9.57B | 13 |
FQ3 2027 (Jul 2027) | 8.89B | -- | 8.8B | 9.06B | 13 |
FQ2 2027 (Apr 2027) | 8.39B | -- | 8.31B | 8.56B | 24 |
FQ1 2027 (Jan 2027) | 0B | -- | 0B | 0B | 13 |
FQ4 2026 (Oct 2026) | 7.41B | -- | 7.33B | 7.55B | 13 |
FQ3 2026 (Jul 2026) | 2.95B | -- | 2.92B | 3.01B | 22 |
FQ2 2026 (Apr 2026) | 2.66B | 14.03 | 2.64B | 2.72B | 13 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.39 | 0.39 | 100% | |
FQ1 2025 (Jan 2025) | 0.41 | 0.41 | 100% | |
FQ4 2024 (Oct 2024) | 1.07 | 1.07 | 100% | |
FQ3 2024 (Jul 2024) | 1.1 | 1.1 | 100% | |
FQ2 2024 (Apr 2024) | 0.86 | 0.86 | 100% | |
FQ1 2024 (Jan 2024) | 5.47 | 5.47 | 100% | |
FQ4 2023 (Oct 2023) | 0.63 | 0.63 | 100% | |
FQ3 2023 (Jul 2023) | 0.74 | 0.74 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $2.29B | $2289M | 100% |
FQ1 2025 (Jan 2025) | $0B | $2.26B | $2257.4M | 100% |
FQ4 2024 (Oct 2024) | $0B | $2.14B | $2138.8M | 100% |
FQ3 2024 (Jul 2024) | $0B | $2.19B | $2189.5M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.98B | $1984.8M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.98B | $1975.1M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.88B | $1878.1M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.95B | $1953.3M | 100% |